Early-pregnancy doxycycline tied to higher pregnancy loss risk; mobile coaching fails to cut postpartum BMI; most fibroid patients avoid retreatment

Listen to this post
read by AI voices · all episodesFirst-trimester doxycycline was associated with higher risk for pregnancy loss than amoxicillin in a claims cohort of 218,234 pregnant patients with respiratory infections, Annals of Internal Medicine reported Nov. 10. A mobile health coaching trial did not lower postpartum BMI in women at risk of gestational diabetes, and most women stayed free of further fibroid procedures for five to 10 years after uterine-sparing treatment.
- Research Nov 10, 2026A retrospective active-comparator cohort study in Annals of Internal Medicine used MarketScan commercial and Medicaid claims to compare first-trimester doxycycline with other antibiotics in pregnancies with a respiratory tract infection or acne. For respiratory infections, doxycycline was associated with higher risk for pregnancy loss than amoxicillin (adjusted relative risk 1.54, 95% CI 1.41 to 1.68, in MarketScan and 1.40, 95% CI 1.28 to 1.53, in Medicaid), with similar results versus macrolides. For acne, the topical clindamycin comparison was significant in MarketScan (adjusted relative risk 1.49, 95% CI 1.26 to 1.76) but not in Medicaid (1.03, 95% CI 0.80 to 1.33).Sources: Annals of Internal Medicine, PubMed
- Technology Nov 12, 2026In a multicenter randomized trial in Australia, Ireland, Spain and the U.K., published in The Lancet Digital Health, 865 pregnant women at risk of gestational diabetes, enrolled at 12 to 24 weeks of gestation, were assigned to personalized mobile health coaching through 12 months postpartum or to usual care. Mean BMI change, the primary end point, did not differ between groups (-0.04 kg/m2 with the intervention versus 0.04 kg/m2 with control). Adverse events were recorded in 18% of the intervention group and 25% of controls.Sources: The Lancet Digital Health, PubMed
- Research Nov 10, 2026An Obstetrics & Gynecology study recontacted 817 participants from two studies of uterine-sparing leiomyoma procedures, who reported any later procedures, with follow-up of 4.0 to 10.5 years. Within five years of the baseline procedure, 79.1% (95% CI 76.2 to 82.1) had no additional uterine procedure, and 64.1% (95% CI 57.7 to 71.2) had none within 10 years. Compared with myomectomy, radiofrequency ablation was associated with a higher retreatment rate (hazard ratio 1.61, 95% CI 1.08 to 2.40).Sources: Obstetrics & Gynecology, PubMed
The weekly innovation roundup for obstetrics and gynecology, published every Sunday for the week before; every item links to its sources. Latest obstetrics and gynecology news · All specialties